Dirithromycin is a macrolide glycopeptide antibiotic. Dirithromycin (Dynabac) is a
more lipid-soluble prodrug derivative of 9S-erythromycyclamine prepared by ...
Physician reviewed dirithromycin patient information - includes dirithromycin
description, dosage and directions.
Dirithromycin is a semi-synthetic macrolide antibiotic pro-drug. Dirithromycin is
converted by hydrolysis during intestinal absorption into the microbiologically ...
Aug 24, 2015 ... Dirithromycin - Get up-to-date information on Dirithromycin side effects, uses,
dosage, overdose, pregnancy, alcohol and more. Learn more ...
By contrast, incubation of adenoid tissue with dirithromycin (0.125 to 1.0 g/ml) for
4 h prior to assembling the organ culture reduced the mucosal damage caused ...
Dirithromycin is the 9-N,11-O-oxazine adduct formed from 9(S)-
erythromycylamine and 2-(2-methoxyeth- oxy)acetaldehyde in which the
Dirithromycin is a pro-drug which is converted non-enzymatically during intestinal
absorption into the microbiologically active moiety erythromycylamine.
After incubation with radiolabeled dirithromycin, antibiotic uptake by PMNs was ...
After removal of extracellular drug, the efflux (release) of dirithromycin from ...
In Vitro Activity of Dirithromycin (LY 237216) Compared with. Activities of Other
Macrolide Antibiotics. KWOK-WOON YUt AND HAROLD C. NEU*. Departments ...
infection including pneumonia and bronchitis in adults and children.3,4 Therefore
, we evaluated the in-vitro activity of dirithromycin, erythromycyclamine and ery-.